Avadel Pharmaceuticals plc
AVDL
$14.20
$0.201.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.67M | -4.92M | -5.04M | -2.63M | -13.82M |
| Total Depreciation and Amortization | 1.07M | 825.00K | 668.00K | 1.04M | 437.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.47M | 4.25M | 4.35M | 5.57M | 4.97M |
| Change in Net Operating Assets | -2.51M | -8.39M | 7.90M | -10.87M | -9.77M |
| Cash from Operations | 12.70M | -8.23M | 7.87M | -6.89M | -18.19M |
| Capital Expenditure | -181.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.07M | 12.32M | 14.91M | 4.93M | 10.55M |
| Cash from Investing | -8.25M | 12.32M | 14.91M | 4.93M | 10.55M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 982.00K | 690.00K | 880.00K | 1.18M | 723.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 982.00K | 690.00K | 880.00K | 1.18M | 723.00K |
| Foreign Exchange rate Adjustments | 1.61M | 224.00K | -877.00K | 518.00K | -34.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.03M | 5.00M | 22.79M | -265.00K | -6.95M |